The study investigated the predictors and the effects of treatment with a second biologic agent in rheumatoid arthritis patients. Data were collected in the GISEA register, an Italian registry that covered 10 years.
Predictors, Features and Effects of First Biologic Switch in Rheumatoid Arthritis within GISEA register: Italian 10-Year Experience / Bernd, Raffeiner; Costantino, Botsios; Paolo, Sfriso; Antonio, Carletto; Domenico, Biasi; Elisa, Gremese; Gianfranco, Ferraccioli; Ferri, Clodoveo; Mauro, Galeazzi; Roberto, Gerli; Paola, Cipriani; Roberto, Giacomelli; Tamara, Ziglioli; Roberto, Gorla; Marcello, Govoni; Antonio, Marchesoni; Fausto, Salaffi; Walter, Grassi; Fabiola, Atzeni; Piercarlo, Sarzi Puttini; Annarita, Giardina; Giovanni, Triolo; Florenzo, Iannone; Giovanni, Lapadula; Leonardo, Punzi. - In: ARTHRITIS AND RHEUMATISM. - ISSN 1529-0131. - STAMPA. - 63:10(2011), pp. S467-S467. (Intervento presentato al convegno ACR tenutosi a Chicago nel 4-9 November 2011).
Predictors, Features and Effects of First Biologic Switch in Rheumatoid Arthritis within GISEA register: Italian 10-Year Experience
FERRI, Clodoveo;
2011
Abstract
The study investigated the predictors and the effects of treatment with a second biologic agent in rheumatoid arthritis patients. Data were collected in the GISEA register, an Italian registry that covered 10 years.Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris